By Justin Walsh[1] It’s an exciting time to be in hemp and CBD! I have attended and spoken at several conferences over the last year. I have been in places as diverse as Seattle, Denver, Dallas, and Orlando. The products I have seen have made me excited for the future of the industry. I have […]
GW Pharmaceuticals
Capitalizing on Legal Hemp!
An Entrepreneur’s Guide By Mark Goldfogel In December of 2018, the U.S. Government legalized hemp; joining China, France, Great Britain and most of the developed world in recognizing that rope is not dope. This ended a prohibition on hemp dating back to 1937 and foretells the end of marijuana prohibition. To date, the dope or […]
First FDA approved cannabis-based drug now available by prescription
The first cannabis-derived medication approved by the Food and Drug Administration is now available by prescription in every state, according to its manufacturer. Epidiolex, manufactured by GW Pharmaceuticals, is intended to treat seizures associated with two rare and severe forms of epilepsy that begin in childhood. The drug is made of cannabidiol (CBD), a component of […]
The drug maker behind the first FDA-approved medication derived from marijuana has revealed how much it’ll cost
A marijuana-derived drug that recently became the first of its kind to win federal approval is not going to be cheap. Called Epidiolex, the drug is designed to treat two rare forms of childhood epilepsy using a cannabis compound called cannabidiol (or CBD) . On a call with investors this week, British-based GW Pharmaceuticals, who […]
The FDA Just Approved the First-Ever Cannabis Based Drug in the U.S.
The Food and Drug Administration (FDA) for the first time approved a drug directly derived from cannabis on Monday, Epidiolex, developed by the British GW Pharmaceuticals. Although several states have legalized the medical and recreational use of marijuana, the federal agency had yet to do so until today. Under the Controlled Substances Act, marijuana is […]
Don’t Expect Joints If the FDA Ever Approves Medical Marijuana
While past marijuana opponents like John Boehner are coming around to legal weed, the Food and Drug Administration isn’t likely to recommend that Americans light up a joint anytime soon. That doesn’t mean that cannabis will never be sanctioned by the FDA in some form, said Commissioner Scott Gottlieb. It’s just highly doubtful that the […]
Marijuana-Based Epilepsy Drug Could Hit The U.S. Market By Mid-2018
A new class of epilepsy medications based on an ingredient derived from marijuana could be available as soon as the second half of 2018 in the United States, pending Food and Drug Administration approval. Officials from GW Pharmaceuticals, the company that developed the drug, on Wednesday announced promising results from a study on 171 patients randomized into treatment and placebo groups. […]
The 7 Largest Marijuana Stocks All Have This Dubious Statistic in Common: These are some lofty valuations with little to show for it.
Seemingly nothing can stop the marijuana industry, or marijuana stocks, at the moment. Over the past couple of years, we’ve witnessed a number of major milestones for the cannabis industry. For example, in 2012, Colorado and Washington became the first states where a majority of voters legalized the sale of recreational marijuana to adults ages […]
DEA and Big Pharma: The Tangled Web of the Opioid Crisis
By Ralph Morgan Cannabis Industry leaders and activists are seemingly the only two groups with a sense of urgency to find a reasonable alternative pain remedy to replace synthetic opioids. Pharmaceuticals are responsible for a death every 19 minutes. Big Pharma, in order to preserve pride and profit, is funding opposition to deter cannabis legalization […]
Big Pharma Seeks to Capitalize on Pain-Reducing Compound Derived From Cannabis
The medicinal properties of cannabidiol (better known as CBD), a compound found in the Cannabis sativa L. plant species, are quickly drawing the attention of scientists, plant-medicine lovers, dietary-supplement companies, venture capitalists, professional athletes and Big Pharma — not to mention people living with serious, chronic medical conditions. Insiders predict the burgeoning market will be […]
